Birdwatch Note
2024-10-14 09:51:28 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
HPVワクチンに問題があるかのような内容の投稿ですが、これは事実と科学的根拠からかけ離れたものです。 HPVワクチンの副反応として報じられてきた諸症状は、ワクチンとは無関係だった(ワクチンを接種した人と接種していない人で発生率に差はみられなかった)ことが、疫学調査によって既に明らかになっています。 https://medical.jiji.com/topics/1184 HPVワクチンは、リスクが小さく、ベネフィットが大きいことが判明しているため、日本以外の先進諸国では接種率が対象者の5～9割程度となっています。 https://minpapi.jp/hpvv-immunization-rate/ ■ 子宮頸がんなどを防ぐHPVワクチン 多くの誤情報がSNSに｜NHK https://www3.nhk.or.jp/news/html/20241002/k10014599111000.html
Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845761333029171477
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845764352592511057
- noteId - 1845764352592511057
- participantId -
- noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
- createdAtMillis - 1728899488959
- tweetId - 1845761333029171477
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- HPVワクチンに問題があるかのような内容の投稿ですが、これは事実と科学的根拠からかけ離れたものです。 HPVワクチンの副反応として報じられてきた諸症状は、ワクチンとは無関係だった(ワクチンを接種した人と接種していない人で発生率に差はみられなかった)ことが、疫学調査によって既に明らかになっています。 https://medical.jiji.com/topics/1184 HPVワクチンは、リスクが小さく、ベネフィットが大きいことが判明しているため、日本以外の先進諸国では接種率が対象者の5～9割程度となっています。 https://minpapi.jp/hpvv-immunization-rate/ ■ 子宮頸がんなどを防ぐHPVワクチン 多くの誤情報がSNSに｜NHK https://www3.nhk.or.jp/news/html/20241002/k10014599111000.html
Note Ratings
| rated at | rated by | |
| 2024-10-17 17:59:59 -0500 | Rating Details | |
| 2024-10-16 21:05:10 -0500 | Rating Details | |
| 2024-10-16 18:37:05 -0500 | Rating Details | |
| 2024-10-15 19:45:24 -0500 | Rating Details | |
| 2024-10-15 18:36:00 -0500 | Rating Details | |
| 2024-10-14 21:01:02 -0500 | Rating Details | |
| 2024-10-14 07:02:11 -0500 | Rating Details | |
| 2024-10-14 06:27:18 -0500 | Rating Details | |
| 2024-10-14 06:27:15 -0500 | Rating Details | |
| 2024-10-14 06:21:55 -0500 | Rating Details | |
| 2024-10-14 06:15:36 -0500 | Rating Details | |
| 2024-10-14 06:14:35 -0500 | Rating Details | |
| 2024-10-14 05:59:52 -0500 | Rating Details | |
| 2024-10-14 05:54:15 -0500 | Rating Details | |
| 2024-10-16 11:06:16 -0500 | Rating Details | |
| 2024-10-16 10:06:04 -0500 | Rating Details | |
| 2024-10-16 03:31:33 -0500 | Rating Details | |
| 2024-10-16 00:35:05 -0500 | Rating Details | |
| 2024-10-15 19:43:02 -0500 | Rating Details | |
| 2024-10-15 18:55:11 -0500 | Rating Details | |
| 2024-10-15 18:41:00 -0500 | Rating Details | |
| 2024-10-15 18:32:32 -0500 | Rating Details | |
| 2024-10-14 22:48:51 -0500 | Rating Details | |
| 2024-10-14 19:41:46 -0500 | Rating Details | |
| 2024-10-14 11:05:54 -0500 | Rating Details | |
| 2024-10-14 10:44:56 -0500 | Rating Details | |
| 2024-10-14 09:29:23 -0500 | Rating Details | |
| 2024-10-14 08:03:36 -0500 | Rating Details | |
| 2024-10-14 06:38:27 -0500 | Rating Details | |
| 2024-10-14 05:55:28 -0500 | Rating Details | |
| 2024-10-14 05:46:35 -0500 | Rating Details | |
| 2024-10-18 20:39:43 -0500 | Rating Details | |
| 2024-10-16 01:34:01 -0500 | Rating Details | |
| 2024-10-15 21:59:37 -0500 | Rating Details | |
| 2024-10-15 20:19:03 -0500 | Rating Details | |
| 2024-10-15 19:14:23 -0500 | Rating Details | |
| 2024-10-15 19:04:29 -0500 | Rating Details | |
| 2024-10-15 18:43:32 -0500 | Rating Details | |
| 2024-10-15 18:34:40 -0500 | Rating Details | |
| 2024-10-14 16:39:28 -0500 | Rating Details | |
| 2024-10-14 13:01:24 -0500 | Rating Details | |
| 2024-10-14 12:17:09 -0500 | Rating Details | |
| 2024-10-14 11:04:08 -0500 | Rating Details | |
| 2024-10-14 10:28:30 -0500 | Rating Details | |
| 2024-10-14 08:46:58 -0500 | Rating Details | |
| 2024-10-14 08:39:18 -0500 | Rating Details | |
| 2024-10-14 08:22:54 -0500 | Rating Details | |
| 2024-10-14 07:51:48 -0500 | Rating Details | |
| 2024-10-14 07:16:41 -0500 | Rating Details | |
| 2024-10-14 07:04:29 -0500 | Rating Details | |
| 2024-10-14 06:31:13 -0500 | Rating Details | |
| 2024-10-14 06:18:01 -0500 | Rating Details | |
| 2024-10-14 06:14:14 -0500 | Rating Details | |
| 2024-10-14 06:03:43 -0500 | Rating Details | |
| 2024-10-14 05:59:07 -0500 | Rating Details | |
| 2024-10-14 05:58:14 -0500 | Rating Details | |
| 2024-10-14 05:53:50 -0500 | Rating Details | |
| 2024-10-14 05:52:04 -0500 | Rating Details | |
| 2024-10-14 05:51:42 -0500 | Rating Details | |
| 2024-10-18 10:53:49 -0500 | Rating Details | |
| 2024-10-16 10:57:32 -0500 | Rating Details | |
| 2024-10-15 23:44:40 -0500 | Rating Details | |
| 2024-10-15 22:34:04 -0500 | Rating Details | |
| 2024-10-15 22:28:43 -0500 | Rating Details | |
| 2024-10-15 20:34:21 -0500 | Rating Details | |
| 2024-10-15 20:32:00 -0500 | Rating Details | |
| 2024-10-15 18:49:31 -0500 | Rating Details | |
| 2024-10-15 18:48:51 -0500 | Rating Details | |
| 2024-10-15 18:48:05 -0500 | Rating Details | |
| 2024-10-15 18:46:43 -0500 | Rating Details | |
| 2024-10-15 18:32:49 -0500 | Rating Details | |
| 2024-10-14 14:03:26 -0500 | Rating Details | |
| 2024-10-14 08:04:05 -0500 | Rating Details | |
| 2024-10-14 07:55:56 -0500 | Rating Details | |
| 2024-10-14 07:14:42 -0500 | Rating Details | |
| 2024-10-14 07:08:39 -0500 | Rating Details | |
| 2024-10-14 06:49:20 -0500 | Rating Details | |
| 2024-10-14 06:47:55 -0500 | Rating Details | |
| 2024-10-14 06:45:47 -0500 | Rating Details | |
| 2024-10-14 06:44:46 -0500 | Rating Details | |
| 2024-10-14 06:28:28 -0500 | Rating Details | |
| 2024-10-14 06:01:58 -0500 | Rating Details | |
| 2024-10-14 05:58:11 -0500 | Rating Details | |
| 2024-10-14 05:58:06 -0500 | Rating Details | |
| 2024-10-14 05:55:43 -0500 | Rating Details | |
| 2024-10-14 05:52:14 -0500 | Rating Details | |
| 2024-10-14 05:51:24 -0500 | Rating Details | |
| 2024-10-14 05:41:49 -0500 | Rating Details | |
| 2024-10-16 12:49:57 -0500 | Rating Details | |
| 2024-10-16 02:43:00 -0500 | Rating Details | |
| 2024-10-16 00:38:49 -0500 | Rating Details | |
| 2024-10-16 00:33:53 -0500 | Rating Details | |
| 2024-10-15 22:19:05 -0500 | Rating Details | |
| 2024-10-15 18:46:32 -0500 | Rating Details | |
| 2024-10-15 18:38:27 -0500 | Rating Details | |
| 2024-10-15 18:34:18 -0500 | Rating Details | |
| 2024-10-15 04:17:41 -0500 | Rating Details | |
| 2024-10-14 17:26:58 -0500 | Rating Details | |
| 2024-10-14 15:45:52 -0500 | Rating Details | |
| 2024-10-14 09:02:24 -0500 | Rating Details | |
| 2024-10-14 08:47:19 -0500 | Rating Details | |
| 2024-10-14 07:56:43 -0500 | Rating Details | |
| 2024-10-14 07:54:11 -0500 | Rating Details | |
| 2024-10-14 06:58:38 -0500 | Rating Details | |
| 2024-10-14 06:58:22 -0500 | Rating Details | |
| 2024-10-14 06:49:10 -0500 | Rating Details | |
| 2024-10-14 05:59:15 -0500 | Rating Details | |
| 2024-10-14 05:57:21 -0500 | Rating Details | |
| 2024-10-14 05:55:51 -0500 | Rating Details | |
| 2024-10-14 05:55:00 -0500 | Rating Details | |
| 2024-10-14 05:52:46 -0500 | Rating Details | |
| 2024-10-14 05:46:15 -0500 | Rating Details | |
| 2024-10-14 05:40:32 -0500 | Rating Details | |
| 2024-10-14 05:36:51 -0500 | Rating Details |